Emerging therapeutic targets for osteoarthritis

References

• Safiri S, Kolahi AA, Smith E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020;79(6):819–828.
   PubMed Web of Science ®Google Scholar
• Standardization of osteoarthritis definitions. Osteoarthritis Cartilage. 2015. Available at https://oarsi.org/research/standardization-osteoarthritis-definitions.
   Google Scholar
• Castaneda S, Roman-Blas JA, Largo R, et al. Osteoarthritis: a progressive disease with changing phenotypes. J Rheumatol. 2014;53(1):1–3.
   Google Scholar
• Deveza LA, Melo L, Yamato TP, et al. Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthritis Cartilage. 2017;25(12):1926–1941.
   PubMed Web of Science ®Google Scholar
• Dell’Isola A, Allan R, Smith SL, et al. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet Discord. 2016;17(1):425–437.
   PubMedGoogle Scholar
• Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589.
   PubMed Web of Science ®Google Scholar
• Higashi H, Barendregt JJ, van Baal PHM. Cost-effectiveness of total hip and knee replacement for the Australian population with osteoarthritis: discrete-event simulation model. PLoS One. 2011;6(9):e25403.
   PubMed Web of Science ®Google Scholar
• Fu K, Robbins SR, McDougall JJ. Osteoarthritis: the genesis of pain. Rheumatology. 2017;57(suppl_4):iv43–iv50.
   Google Scholar
• McCoy AM. Animal models of osteoarthritis: comparisons and key considerations. Vet Pathol. 2015;52(5):803–818.
   PubMed Web of Science ®Google Scholar
• Sun MMG, Beier F, Pest MA. Recent developments in emerging therapeutic targets of osteoarthritis. Curr Opin Rheumatol. 2017;29(1):96–102.
   PubMed Web of Science ®Google Scholar
• Latourte A, Kloppenburg M, Richette P. Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol. 2020;16(12):673–688.
   PubMed Web of Science ®Google Scholar
• Vincent TL. Of mice and men: converging on a common molecular understanding of osteoarthritis. Lancet Rheumatol. 2020;2(10):e633–45.
   PubMedGoogle Scholar
• Cuervo AM. Autophagy: many paths to the same end. Mol Cell Biochem. 2004;263(1/2):55–72.
   Web of Science ®Google Scholar
• Lotz MK, Carames B. Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nat Rev Rheumatol. 2011;7(10):579–587.
   PubMed Web of Science ®Google Scholar
• Terman A, Kurz T, Navratil M, et al. Mitochondrial turnover and aging of long-living postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal. 2010;12(4):503–535.
   PubMed Web of Science ®Google Scholar
• Carmes B, Taniguchi N, Otsuki S, et al. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 2010;62(3):791–801.
   PubMedGoogle Scholar
• Wang C, Yao Z, Zhang Y, et al. Metformin mitigates cartilage degradation by activating AMPK/SIRT1-mediated autophagy in a mouse osteoarthritis model. Font Pharmacol. 2020;11:1114.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang Y, Li X, et al. Alterations of autophagy in knee cartilage by treatment with treadmill exercise in a rat osteoarthritis model. Int J Mol Med. 2019;43(1):336–344.
   PubMed Web of Science ®Google Scholar
• Carames B, Hasegawa A, Taniguchi, et al. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann Rheum Dis. 2012;71(4):575–581.
   PubMed Web of Science ®Google Scholar
• Takayama K, Kawakami Y, Kobayashi M, et al. Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res Ther. 2014;16(6):482–492.
   PubMed Web of Science ®Google Scholar
• Ma L, Liu Y, Zhao X, et al. Rapamycin attenuates articular cartilage degeneration by inhibiting β-catenin in a murine model of osteoarthritis. Connect Tissue Res. 2019;60(5):452–462.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li X, Jin A. Rapamycin inhibits NF-κB activation by autophagy to reduce catabolism in human chondrocytes. J Invest Surg. 2020;33(9):861–873.
   PubMed Web of Science ®Google Scholar
• Luna-Preitschopf AD, Zwickl H, Nehrer S, et al. Rapamycin maintains the chondrocytic phenotype and interferes with inflammatory cytokine induced processes. Int J Mol Sci. 2017;18(7):1494–1509.
   PubMed Web of Science ®Google Scholar
• Sun K, Luo J, Guo J, et al. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020;28(4):400–409.
   PubMed Web of Science ®Google Scholar
• Laragione T, Gulko PS. mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol Med. 2010;16(9–10):352–358.
   PubMed Web of Science ®Google Scholar
• Guo SM, Wang JX, Li J, et al. Identification of gene expression profiles and key genes in subchondral bone of osteoarthritis using weighted gene coexpression network analysis. J Cell Biochem. 2018;119(9):7687–7695.
   PubMed Web of Science ®Google Scholar
• Lin C, Shao Y, Zeng C, et al. Blocking PI3K/AKT signalling inhibits bone sclerosis in subchondral bone and attenuates post-traumatic osteoarthritis. J Cell Physiol. 2018;223(8):6135–6147.
   Google Scholar
• Lin C, Liu L, Zeng C, et al. Activation of mTORC1 in subchondral bone preosteoblasts promotes osteoarthritis by stimulating bone sclerosis and secretion of CXCL12. Bone Res. 2019;7:5.
   PubMed Web of Science ®Google Scholar
• Lu J, Ji M, Zhang X, et al. MicroRNA-218-5p as a potential target for the treatment of human osteoarthritis. Mol Ther. 2017;25(12):2676–2688.
   PubMed Web of Science ®Google Scholar
• Cai C, Min S, Yan B, et al. MiR-27a promotes the autophagy and apoptosis of IL-1β treated-articular chondrocytes in osteoarthritis through PI3K/AKT/mTOR signaling. Aging (Albany NY). 2019;11(16):6371–6384.
   PubMedGoogle Scholar
• Martin JA, Buckwalter JA. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg. 2003;85:106–110.
   PubMed Web of Science ®Google Scholar
• McCulloch K, Litherland GJ, Rai TS. Cellular senescence in osteoarthritis pathology. Aging Cell. 2017;16(2):210–218.
   PubMed Web of Science ®Google Scholar
• Philipot D, Guerit D, Platano D, et al. p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis. Arthritis Res Ther. 2014;16(1):58–70.
   PubMed Web of Science ®Google Scholar
• Vinatier C, Dominguez E, Guicheux J, et al. Role of inflammation-autophagy-senescence integrative network in osteoarthritis. Front Physiol. 2018;9. DOI:10.3389/fphys.2018.00706
   PubMed Web of Science ®Google Scholar
• Acosta JC, Banito A, Wuestefeld, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978–990.
   PubMed Web of Science ®Google Scholar
• Greene MA, Loeser RF. Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1966–1971.
   PubMed Web of Science ®Google Scholar
• Dvir-Ginzberg M, Mobasheri A, Kumar A. The role of sirtuins in cartilage homeostasis and osteoarthritis. Curr Rheumatol Rep. 2016;18:42–51.
   PubMed Web of Science ®Google Scholar
• Zhao G, Wang H, Xu C, et al. SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation. Aging (Albany NY). 2016;8(10):2308–2323.
   PubMedGoogle Scholar
• Collins JA, Japustina M, Bolduc JA, et al. Sirtuin 6 (SIRT6) regulates redox homeostasis and signaling events in human articular chondrocytes. Free Radic Biol Med. 2021;166:90–103.
   PubMed Web of Science ®Google Scholar
• Nagai K, Matsushita T, Matsuzaki T, et al. Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes. Osteoarthritis Cartilage. 2015;23(8):1412–1420.
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen L, Wang Y, et al. Overexpression of sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development. Sci Rep. 2015;5(1):17602–17613.
   PubMed Web of Science ®Google Scholar
• Jeon OH, Kim C, Laberge RM, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017;23(6):775–781.
   PubMed Web of Science ®Google Scholar
• Farr JN, Xu M, Weivoda MM, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017;23(9):1072–1079.
   PubMed Web of Science ®Google Scholar
• Lane N, Hsu B, Visich J, et al. A phase 2, randomized, double-blind, placebo-controlled study of senolytics molecule UBX0101 in the treatment of painful knee osteoarthritis. Osteoarthritis Cartilage. 2021;29:S10–S432.
   Web of Science ®Google Scholar
• Faust HJ, Zhang H, Han J, et al. IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis. J Clin Invest. 2020;130(10):5493–5507.
   PubMed Web of Science ®Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33–42.
   PubMed Web of Science ®Google Scholar
• Van der Kraan PM. The changing role of TGFβ in healthy, ageing and osteoarthritis joints. Nat Rev Rheumatol. 2017;13(3):155–163.
   PubMed Web of Science ®Google Scholar
• Maumus M, Noel D, Ea HK, et al. Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypes. Osteoarthritis Cartilage. 2020;28(10):1373–1384.
   PubMed Web of Science ®Google Scholar
• Wang R, Xu B, Xu H. TGF-β1 promoted chondrocyte proliferation by regulating Sp1 through MSC-exosomes derived miR-135b. Cell Cycle. 2018;17(24):2756–2765.
   PubMed Web of Science ®Google Scholar
• Kim MK, Ha CW, In Y, et al. A multicenter, double-blind, phase III clinical trial to evaluate the efficacy and safety of a cell and gene therapy in knee osteoarthritis patients. Hum Gene Ther Clin Dev. 2018;29(1):48–59.
   PubMed Web of Science ®Google Scholar
• Guermazi A, Kalsi G, Niu J, et al. Structural effects of intra-articular TGF-β1 in moderate to advanced knee osteoarthritis: MRI-based assessment in a randomized control trial. BMC Musculoskelet Disord. 2017;18(1). DOI:10.1186/s12891-017-1830-8.
   Google Scholar
• Chen R, Mian M, Fu M, et al. Attenuation of the progression of articular cartilage degeneration by inhibition of TGF-β1 signaling in a mouse model of osteoarthritis. Am J Pathol. 2015;185(11):2875–2885.
   PubMed Web of Science ®Google Scholar
• Thielen NGM, van der Kraan PM, van Caam APM. TGFβ/BMP signalling pathway in cartilage homeostasis. Cells. 2019;8(9):969.
   PubMed Web of Science ®Google Scholar
• Bush JR, Beier F. TGF-β and osteoarthritis – the good and the bad. Nat Med. 2013;19(6):667–669.
   PubMed Web of Science ®Google Scholar
• Appleton CTG, Usmani SE, Bernier SM, et al. Transforming growth factor α suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis Rheum. 2007;56(11):3693–3705.
   PubMedGoogle Scholar
• Sun H, Wu Y, Pan Z, et al. Gefitinib for epidermal growth factor receptor activated osteoarthritis subpopulation treatment. EBioMedicine. 2018;32:223–233.
   PubMed Web of Science ®Google Scholar
• Wei Y, Luo L, Gui T, et al. Targeting cartilage EGFR pathway for osteoarthritis treatment. Sci Transl Med. 2021;13(576). DOI:10.1126/scitranslmed.abb3946.
   Web of Science ®Google Scholar
• Bellini M, Pest MA, Miranda-Rodrigues M, et al. Overexpression of MIG-6 in the cartilage induces an osteoarthritis-like phenotype in mice. Arthritis Res Ther. 2020;22(1):119.
   PubMed Web of Science ®Google Scholar
• Qin L, Beier F. EGFR signaling: friend or foe for cartilage? JBMR Plus. 2019;3(2):e10177.
   PubMedGoogle Scholar
• Jia H, Ma X, Tong W, et al. EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation. Proc Natl Acad Sci USA. 2016;113(50):14360–14365.
   PubMed Web of Science ®Google Scholar
• Regard JB, Zhong Z, Williams BO, et al. Wnt signaling in bone development and disease: making stronger bone with Wnts. Cold Spring Harb Perspect Biol. 2012;4(12):a007997–a007997.
   PubMed Web of Science ®Google Scholar
• Zhu M, Tang D, Wu Q, et al. Activation of β-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult β-catenin conditional activation mice. J Bone Miner Res. 2009;24(1):12–21.
   PubMed Web of Science ®Google Scholar
• Zhu M, Chen M, Zuscik M, et al. Inhibition of β-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum. 2008;58(7):2053–2064.
   PubMedGoogle Scholar
• Lietman C, Wu B, Lechner S, et al. Inhibition of Wnt/β-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis. JCI Insight. 2018;3(3):e96308.
   PubMed Web of Science ®Google Scholar
• van den Bosch MH, Blom AB, van de Loo FA, et al. Induction of matrix metalloproteinase expression by synovial Wnt signaling and association with disease progression in early symptomatic osteoarthritis. Arthritis Rheum. 2017;69(10):1978–1983.
   Web of Science ®Google Scholar
• Yazici Y, McAlindon TE, Gibofsky A, et al. A phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Osteoarthritis Cartilage. 2021;29(5):654–666.
   PubMed Web of Science ®Google Scholar
• Tambiah JRS, Kennedy S, Swearingen CJ, et al. Individual participant symptom responses to intra-articular lorecivivint in knee osteoarthritis: post hoc analysis of a phase 2B trial. Rheumatol Ther. 2021;8(2):973–985.
   PubMed Web of Science ®Google Scholar
• Yazici Y, McAlindon TE, Gibofsky A, et al. Lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and wnt pathway modulator for treatment of knee osteoarthritis: a phase 2 randomized trial. Arthritis Rheum. 2020;72(10):1694–1706.
   PubMed Web of Science ®Google Scholar
• Robinson WH, Lepus CM, Wang Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580–592.
   PubMed Web of Science ®Google Scholar
• Wojdasiewicz P, Poniatowski LA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014;2014:1–19.
   Web of Science ®Google Scholar
• Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013;5(2):77–94.
   PubMedGoogle Scholar
• Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249–257.
   PubMed Web of Science ®Google Scholar
• Barreto G, Sandelin J, Salem A, et al. Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints. Acta Orthop. 2017;88(3):326–333.
   PubMed Web of Science ®Google Scholar
• Liu XJ, Liu T, Chen G, et al. TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation. Sci Rep. 2016;6:28188.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier E, Dorner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rhematol. 2020;16(3):155–166.
   PubMed Web of Science ®Google Scholar
• Lee W, Ruijgrok L, Klerk BB, et al. Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res. 2018;70(9):1320–1325.
   Web of Science ®Google Scholar
• Kedor C, Detert J, Rau R, et al. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of a randomized, double-blind, placebo controlled, multi-centre, investigator-initiated trial (OA TREAT). Ann Rheum Dis. 2020;79(Suppl 1):115–116.
   Google Scholar
• Waller KA, Zhang LX, Elsaid KA, et al. Role of lubricin and boundary lubrication in the prevention of chondrocyte apoptosis. Proc Natl Acad Sci USA. 2013;110(15):5852–5857.
   PubMed Web of Science ®Google Scholar
• Iqbal SM, Leonard C, Regmi SC, et al. Lubricin/Proteoglycan 4 binds to and regulates the activity of toll-like receptors in vitro. Sci Rep. 2016;6(1):18910.
   PubMedGoogle Scholar
• Al-Sharif A, Jamal M, Zhang LX, et al. Lubricin/Proteoglycan 4 binding to CD44 receptor: a mechanism of the suppression of proinflammatory cytokine-induced synoviocytes proliferation by lubricin. Arthritis Rheum. 2015;67(6):1503–1513.
   PubMed Web of Science ®Google Scholar
• Maenohara Y, Chijimatsu R, Tachibana N, et al. Lubricin contributes to homeostasis of articular cartilage by modulating differentiation of superficial zone cells. J Bone Miner Res. 2021;36(4):792–802.
   PubMed Web of Science ®Google Scholar
• Nemirov D, Nakagawa Y, Sun Z, et al. Effect of lubricin mimetics on the inhibition of osteoarthritis in a rat anterior cruciate ligament transection model. Am J Sports Med. 2020;48(3):624–634.
   PubMed Web of Science ®Google Scholar
• Wu CL, Harasymowicz NS, Klimak MA, et al. The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartilage. 2020;28(5):544–54.
   PubMed Web of Science ®Google Scholar
• Blom AB, van Lent PLEM, Holthuysen AEM, et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage. 2004;12(8):627–635.
   PubMed Web of Science ®Google Scholar
• Wu CL, McNeill J, Goon K, et al. Conditional macrophage depletion increases inflammation and does not inhibit the development of osteoarthritis in obese macrophage fas-induced apoptosis-transgenic mice. Arthritis Rheum. 2017;69(9):1772–1783.
   Web of Science ®Google Scholar
• Grol MW, Lee BH. Gene therapy for repair and regeneration of bone and cartilage. Curr Opin Pharmacol. 2018;40:59–66.
   PubMed Web of Science ®Google Scholar
• Jenei-Lanzl Z, Meurer A, Zaucke F. Interleukin-1β signaling in osteoarthritis – chondrocytes in focus. Cell Signal. 2019;53:212–223.
   PubMed Web of Science ®Google Scholar
• Chevalier X, Goupille P, Beaulieu AD, et al. Intraarticular injection of Anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2009;61(3):344–352.
   PubMed Web of Science ®Google Scholar
• Nixon AJ, Grol MW, Lang HM, et al. Disease-modifying osteoarthritis treatment with interleukin-1 receptor antagonist gene therapy in small and large animal models. Arthritis Rheum. 2018;70(11):1757–1768.
   PubMed Web of Science ®Google Scholar
• Stone A, Grol MW, Ruan MZC, et al. Combinatorial Prg4 and Il-1ra Gene Therapy Protects Against Hyperalgesia and Cartilage Degeneration in Post-Traumatic Osteoarthritis. Hum Gene Ther. 2018;30(2):225–235.
   PubMed Web of Science ®Google Scholar
• Spil WEV, Kubassova O, Boesen M, et al. Osteoarthritis phenotypes and novel therapeutic targets. Biochem Pharmacol. 2019;165:41–48.
   PubMed Web of Science ®Google Scholar
• Moon PM, Shao ZY, Wambiekele, et al. Global deletion of pannexin 3 resulting in accelerated development of aging-induced osteoarthritis in mice. Arthritis Rheum. 2021;73(7):1178–1188.
   Web of Science ®Google Scholar
• Moon PM, Penuela S, Barr K, et al. Deletion of Panx3 prevents the development of surgically induced osteoarthritis. J Mol Med. 2015;93(8):845–856.
   PubMed Web of Science ®Google Scholar
• O’Conor CJ, Griffin TM, Leidtke W, et al. Increased susceptibility of Trpv4 -deficient mice to obesity and obesity-induced osteoarthritis with very high-fat diet. Ann Rheum Dis. 2013;72(2):300–304.
   PubMed Web of Science ®Google Scholar
• O’Conor CJ, Ramalingam S, Zelenki NA, et al. Cartilage-specific knockout of the mechanosensory ion channel TRPV4 decreases age-related osteoarthritis. Sci Rep. 2016;6(1):29053.
   PubMedGoogle Scholar
• Clark AL, Votta BJ, Kumar S, et al. Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis in Trpv4-deficient mice. Arthritis Rheum. 2010;62(10):2973–2983.
   PubMedGoogle Scholar
• Ratneswaran A, Beier F. An approach towards accountability: suggestions for increased reproducibility in surgical destabilization of medial meniscus (DMM) models. Osteoarthritis Cartilage. 2017;25(11):1747–1750.
   PubMed Web of Science ®Google Scholar